Form 4 for AURA Aura Biosciences, Inc.
Accepted 2023-11-07 00:00:00 ET · period of report 2023-11-06 · accession 0000950170-23-060499 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2023-11-07 | 2023-11-06 | AURA | de los Pinos Elisabet | See Remarks, Dir | S - Sale+OE | $12.03 | -7,449 | 177.3K | -4% | -$89.6K |
| DT | 2023-11-07 | 2023-11-06 | AURA | de los Pinos Elisabet | See Remarks, Dir | M - OptEx | $2.74 | +3,800 | 184.7K | +2% | +$10.4K |
| DT | 2023-11-07 | 2023-11-06 | AURA | de los Pinos Elisabet | See Remarks, Dir | M - OptEx | $0.00 | -3,800 | 361.2K | -1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-06 | S | D | 7,449 | $12.03 | 177,291 | D | — | — | (F2) The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.00 to $12.13, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2023-11-06 | M | A | 3,800 | $2.74 | 184,740 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2023-11-06 | M | D | 3,800 | $0.00 | 361,163 | D | $2.74 · — to 2028-02-21 | 3,800 Common Stock | (F4) This option is fully vested. |